Work

Longitudinal Safety of Luspatercept in the Treatment of Anemia in Patients with Myelofibrosis: Results from the ACE-536-MF-001 Study

Year: 2023

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2023-174453

Authors: Rami S. Komrokji, Aaron T. Gerds, Claire N Harrison, Jean-Jacques Kiladjian, Ruben Mesa, Prithviraj Bose, Fabian Sanabria, Niloufar Marsousi, Ana Carolina Giuseppi, Huijing Jiang, Francesco Passamonti

Institutions: Moffitt Cancer Center, Cleveland Clinic, Guy's and St Thomas' NHS Foundation Trust, Hôpital Saint-Louis, Wake Forest Baptist Comprehensive Cancer Center, The University of Texas MD Anderson Cancer Center, Bristol-Myers Squibb (Switzerland), Bristol-Myers Squibb (United States), University of Milan

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4389259064

Cites:

Cited by: 2

Related to: 10